Form 4: Centene Director Christopher Coughlin Reports Stock Transactions
SEC Form 4 Filing
Director Christopher Coughlin reports acquisition of restricted stock units and holdings in a grantor retained annuity trust.
Summary
- On May 13, 2025, Christopher Coughlin, a director of Centene Corp, acquired 3,579 shares of restricted stock units.
- These restricted stock units will vest on the earlier of May 13, 2026, or the date of Centene's next annual meeting of stockholders.
- The reported transaction also indicates that Coughlin indirectly owns 30,054 shares of common stock through a grantor retained annuity trust.
- Coughlin also directly owns 10,000 shares of common stock and has options to buy 10,000 shares at $80.57, exercisable from February 7, 2025, to February 7, 2032.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports required insider transactions without indicating positive or negative performance.
Positives
- The acquisition of restricted stock units aligns the director's interests with the company's performance.
- The grantor retained annuity trust structure allows for potential estate planning benefits.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.
Comparison to Industry Standards
- Tracking insider transactions is a common practice in financial analysis.
- Comparing the size and frequency of insider transactions at Centene to those of its peers (e.g., UnitedHealth Group, Anthem) can provide insights into management's confidence and alignment with shareholder interests.
- The vesting schedule of the restricted stock units is typical for executive compensation packages.
Stakeholder Impact
- Shareholders can use this information to assess the alignment of management's interests with their own.
- The transactions themselves are unlikely to have a significant immediate impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date Common Stock Option (right to buy) becomes exercisable |
| 02/07/2032 | Expiration date of Common Stock Option (right to buy) |
| 05/13/2025 | Date of transaction: acquisition of restricted stock units. |
| 05/13/2026 | Vesting date of restricted stock units (or earlier if next annual meeting). |
| 05/14/2025 | Date of signature for the Form 4 filing. |
Keywords
Centene, Director, Stock Options, Restricted Stock Units, Grantor Retained Annuity Trust, Beneficial Ownership, Form 4, CNC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.